Abstract
Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner.
Original language | English |
---|---|
Pages (from-to) | 219-220 |
Number of pages | 2 |
Journal | Nature Reviews Drug Discovery |
Volume | 19 |
Issue number | 4 |
DOIs |
|
Publication status | Published - 1 Apr 2020 |